Browse > Article

Symptom Questionnaire and Laboratory Findings in Subjects with Airflow Limitation: a Nation-wide Survey  

Hwang, Yong Il (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Kim, Young Chul (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Lee, Jae Ho (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Kang, Min Jong (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Kim, Dong Gyu (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Kim, Soo Ock (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Jang, Tae Won (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Lee, Min Ki (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Ahn, Youngsoo (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Yoo, Jee Hong (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Jung, Ki-Suck (On Behalf of the COPD Survey Organizing Committee, Korean Academy of Tuberculosis and Respiratory Diseases)
Publication Information
Tuberculosis and Respiratory Diseases / v.63, no.6, 2007 , pp. 480-485 More about this Journal
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not fully reversible. COPD has systemic effects, such as skeletal muscle dysfunction and abnormal weight loss. It also has been suggested that COPD is related to other chronic disease, such as cardiovascular disease, osteoporosis, and anemia. The aim of this study was to evaluate a symptom questionnaire and laboratory findings in subjects with air flow limitation. Methods: We evaluated a symptom questionnaire and laboratory findings in subjects with airflow limitation detected by spirometry in conjunction with the Second Korean National Health and Nutrition Examination Survey. A total of 9,243 adults over the age of 18 were recruited. Among the adults, we finally analyzed 2,217 subjects who met the acceptability and repeatability criteria of spirometry, showed normal findings on chest radiography, and were older than 40 years of age. Results: There were 288 subjects with airflow limitation as determined by spirometry. The frequency of respiratory symptoms such as cough, sputum and wheezing were significantly higher in subjects with airflow limitation (p <0.01). Hemoglobin and hematocrit levels were higher in subjects with airflow limitation (hemoglobin level 13.98 mg/dL vs. 13.62 mg/dL, hematocrit 42.10% vs. 40.89%; p<0.01). The HDL cholesterol level was lower in subjects with airflow limitation (44.95 mg/dL vs. 45.60 mg/dL; p<0.01). There was no significant difference in the total cholesterol, triglyceride, blood urea nitrogen, creatinine, and fasting glucose levels. Conclusion: In subjects with airflow limitation, prevalence of respiratory symptoms was higher than in normal spirometry subjects and the levels of hemoglobin and the hematocrit were higher. The HDL cholesterol level was lower in subjects with airflow limitation.
Keywords
Chronic obstructive pulmonary disease; Airflow limitation; Symptom questionnaire; Laboratory findings; Systemic effect;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Murray CJ, Lopez AD. Evidence-based health policy-- lessons from the Global Burden of Disease Study. Science 1996;274:740-3   DOI   ScienceOn
2 Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease. Lancet 1997;349:1436-42   DOI   ScienceOn
3 Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46   DOI   ScienceOn
4 Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-20   DOI   ScienceOn
5 John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest 2005;127:825-9   DOI   ScienceOn
6 Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survery. Am J Respir Crit Care Med 2005;172:842-7   DOI   ScienceOn
7 National Heart, Lung, and Blood Institute and World Health Organization. Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda, MD, USA: National Heart, Lung, and Blood Institute, National Institutes of Health; 2006. [cited 25 January 2007]. Available from: http:// www.goldcopd.com
8 Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486-97   DOI   ScienceOn
9 Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007;29:923-9   DOI   ScienceOn
10 Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005;2:8-11   DOI   ScienceOn
11 Calverley PM. COPD: early detection and intervention. Chest 2000;117:365S-71S   DOI   ScienceOn
12 Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370:797-9   DOI   ScienceOn
13 Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504   DOI   ScienceOn
14 Choi JK, Paek D, Lee JO. Normal predictive values of spirometry for Korean population. Tuberc Respir Dis 2005;58:230-42   DOI